Our data showed that PS and PRO alone or in combination improved TNF-α and IL-1β immunolabeling, two critical pro-inflammatory cytokines related to CRC pathogenesis [46], in the colon tissue compared to the 1,2-DMH-challenged controls, reaching the level of the sham group. The gene discussed is TNF; the disease is colorectal carcinoma.